Sandy Nerette Fontain

Cost-Effectiveness of Rapid Syphilis Screening in Prenatal HIV Testing Programs in Haiti

Bruce R. Schackman, Christopher P. Neukermans, Sandy Nerette Fontain et al. · PLoS Medicine · 2007 · 63 citations · Full text

Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease

Amita Gupta, Susan Swindells, Soyeon Kim et al. · Clinical Infectious Diseases · 2019 · 37 citations · Full text

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study

Beatriz Grinsztejn, Michael D. Hughes, Justin Ritz et al. · The Lancet HIV · 2019 · 36 citations · Full text

Sexual Health, Epidemiology, Actg A5288 +9

Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial

Anchalee Avihingsanon, Michael D. Hughes, Robert A. Salata et al. · Journal of the International AIDS Society · 2022 · 13 citations · Full text

Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study

Nishi Suryavanshi, Matthew Murrill, Amita Gupta et al. · Clinical Infectious Diseases · 2019 · 10 citations · Full text